Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Feng Wan has a total of 86 co-authors. Here are the top co-authors by number of shared publications:

  • Zirong Chen

    Department of General Intensive Care Unit, Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Engineering Research Center for Critical Care Medicine, Henan Key Laboratory of Critical Care Medicine, Henan Key Laboratory of Sepsis in Health Commission, Zhengzhou Key Laboratory of Sepsis, Henan Sepsis Diagnosis and Treatment Center, Zhengzhou, China

    9 shared publications
  • Xiaolin Zhang

    Department of Neurosurgery, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    7 shared publications
  • Fangyong Dong

    Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University Science and Technology, Wuhan, China

    6 shared publications
  • Suojun Zhang

    Department of General Intensive Care Unit, Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Engineering Research Center for Critical Care Medicine, Henan Key Laboratory of Critical Care Medicine, Henan Key Laboratory of Sepsis in Health Commission, Zhengzhou Key Laboratory of Sepsis, Henan Sepsis Diagnosis and Treatment Center, Zhengzhou, China

    6 shared publications
  • Bin Zhang

    Department of Physiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    5 shared publications
  • Peng Peng

    Department of General Intensive Care Unit, Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Engineering Research Center for Critical Care Medicine, Henan Key Laboratory of Critical Care Medicine, Henan Key Laboratory of Sepsis in Health Commission, Zhengzhou Key Laboratory of Sepsis, Henan Sepsis Diagnosis and Treatment Center, Zhengzhou, China

    5 shared publications

Latest Publications

  • Open Access

    The malignant synapse: architecture, signal integration, and therapeutic vulnerabilities in glioma

    by Bo Yuan, Xiaolin Zhang, Dongying Zheng, Haoran Wang, Xiran Jiang, Bin Zhang, Feng Wan

    Emerging evidence has fundamentally reshaped the neuro-oncological paradigm, revealing that gliomas and brain metastases are not isolated cellular masses but synaptically integrated entities within the brain’s neural circuitry. This review comprehensively delineates the architecture and multi-modal signaling landscape of the “malignant synapse.” We explore how diverse pre-synaptic inputs—encompassing glutamatergic, cholinergic, and GABAergic signals—are structurally anchored by matricellular organizers (like thrombospondins) and proteolytically cleaved factors (like sNLGN3). Post-synaptically, glioma cells deploy a sophisticated array of effectors to translate these neural inputs. Through a convergence of electrochemical (AMPAR-mediated), mechanosensory (CSPG4-PIEZO1 cascade), and metabolic (CHRM3 and TrkB) axes, these diverse signals universally ignite the PI3K-mTOR signaling hub, which is further amplified across the tumor mass via the Connexin-43-coupled tumor microtube (TM) syncytium. Recognizing this profound reliance on neural inputs exposes a critical therapeutic vulnerability. We systematically evaluate pharmacological strategies to disconnect these malignant circuits, highlighting the repurposing of neuroactive drugs—including perampanel, gabapentin, and bumetanide—to effectively stall tumor progression. Finally, we address formidable translational challenges, such as blood-brain barrier penetrance and off-target neurotoxicity. We also outline future frontiers, particularly leveraging spatial multi-omics to decode how synaptic signaling orchestrates the tumor immune microenvironment. Ultimately, dismantling the neuron-glioma axis represents a transformative frontier in conquering intractable brain cancers.

  • Open Access

    Targeting aberrant DNA methylation across subtypes of pediatric high-grade glioma inhibits tumor growth and RUNX3 represents a targetable methylated tumor suppressor

    by Minhai Dong, Xiaolin Zhang, Xiran Jiang, Lijun Wan, Wang Xiang, Chongzhu Fan, Hainan Li, Mingyao Lai, Dan Zhu, Linbo Cai, et al.

    Aberrant DNA methylation is one of the most prevalent epigenetic alterations in cancer, and reversing DNA methylation holds promise as a therapeutic strate

  • Open Access

    Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EphA2

    by Zirong Chen, Junhong Wang, Peng Peng, Guohao Liu, Minhai Dong, Xiaolin Zhang, Yang Zhang, Xue Yang, Lijun Wan, Wang Xiang, et al.

    Rationale: Glioma stem cells (GSCs) have emerged as pivotal drivers of tumor malignancy, sustained by various microenvironmental factors, including immune molecules and hypoxia. In our previous study, we elucidated the significant role of transforming growth factor beta-induced protein (TGFBI), a protein secreted by M2-like tumor-associated macrophages, in promoting the malignant behavior of glioblastoma (GBM) under normoxic conditions. Building upon these findings, the objective of this study was to comprehensively explore the crucial role and underlying mechanisms of autocrine TGFBI in GSCs under hypoxic conditions.


  • Open Access

    Molecular characterization of sub-frontal recurrent medulloblastomas reveals potential clinical relevance

    by Zirong Chen, Huaitao Yang, Jiajia Wang, Guoxian Long, Qingsong Xi, Tao Chen, Yue He, Bin Zhang, Feng Wan

    Background: Single recurrence in the sub-frontal region after cerebellar medulloblastoma (MB) resection is rare and the underlying molecular characteristics have not been specifically addressed.Methods: We summarized two such cases in our center. All five samples were molecularly profiled for their genome and transcriptome signatures.Results: The recurrent tumors displayed genomic and transcriptomic divergence. Pathway analysis of recurrent tumors showed functional convergence in metabolism, cancer, neuroactive ligand–receptor interaction, and PI3K-AKT signaling pathways. Notably, the sub-frontal recurrent tumors had a much higher proportion (50–86%) of acquired driver mutations than that reported in other recurrent locations. The acquired putative driver genes in the sub-frontal recurrent tumors functionally enriched for chromatin remodeler-associated genes, such as KDM6B, SPEN, CHD4, and CHD7. Furthermore, the germline mutations of our cases showed a significant functional convergence in focal adhesion, cell adhesion molecules, and ECM–receptor interaction. Evolutionary analysis showed that the recurrence could be derived from a single primary tumor lineage or had an intermediate phylogenetic similarity to the matched primary one.Conclusion: Rare single sub-frontal recurrent MBs presented specific mutation signatures that might be related to the under-dose radiation. Particular attention should be paid to optimally covering the sub-frontal cribriform plate during postoperative radiotherapy targeting.

  • Construction and Verification of an RNA-Binding Protein-Associated Prognostic Model for Gliomas

    by Peng Peng, Zi-Rong Chen, Xiao-Lin Zhang, Dong-Sheng Guo, Bin Zhang, Xi-Miao He, Feng Wan

    Objective To construct and verificate an RNA-binding protein (RBP)-associated prognostic model for gliomas using integrated bioinformatics analysis. Methods RNA-sequencing and clinic pathological data of glioma patients from The Cancer Genome Atlas (TCGA) database and the Chinese Glioma Genome Atlas database (CGGA) were downloaded. The aberrantly expressed RBPs were investigated between gliomas and normal samples in TCGA database. We then identified prognosis related hub genes and constructed a prognostic model. This model was further validated in the CGGA-693 and CGGA-325 cohorts. Results Totally 174 differently expressed genes-encoded RBPs were identified, containing 85 down-regulated and 89 up-regulated genes. We identified five genes-encoded RBPs (ERI1, RPS2, BRCA1, NXT1, and TRIM21) as prognosis related key genes and constructed a prognostic model. Overall survival (OS) analysis revealed that the patients in the high-risk subgroup based on the model were worse than those in the low-risk subgroup. The area under the receiver operator characteristic curve (AUC) of the prognostic model was 0.836 in the TCGA dataset and 0.708 in the CGGA-693 dataset, demonstrating a favorable prognostic model. Survival analyses of the five RBPs in the CGGA-325 cohort validated the findings. A nomogram was constructed based on the five genes and validated in the TCGA cohort, confirming a promising discriminating ability for gliomas. Conclusion The prognostic model of the five RBPs might serve as an independent prognostic algorithm for gliomas.


  • Clinical features and outcomes of pediatric intracranial gliomas: results from single center’s 226 cases and corroborated with SEER database

    by Zirong Chen, Zhongyin Guo, Junhong Wang, Dan Cao, Yu Xu, Fangyong Dong, Feng Wan

    Background Pediatric gliomas are the most common central nervous system (CNS) tumors in children and adolescents and show different clinical and histopathological characteristics from the adult. The prognostic factors were poorly defined in pediatric intracranial gliomas. Methods We collected pediatric intracranial glioma cases in our institution between February 2011 and June 2022. The patient clinical data, tumor growth characteristics, treatments, and follow-up data were analyzed by Cox regression analysis to identify impact factors on the prognosis of pediatric intracranial glioma patients. To corroborate our data, an independent cohort of pediatric intracranial glioma from the Surveillance, Epidemiology, and End Results Program (SEER) database was analyzed. Results A total of 181 cases of pediatric low-grade glioma (PLGG) and 45 cases of pediatric high-grade glioma (PHGG) were included. In multivariate Cox regression analysis, tumor size > 59.5 mm (p = 0.006) and non-gross total resection (non-GTR; subtotal resection, STR, p = 0.042; biopsy, p = 0.012) were associated with decreased overall survival (OS) in PLGG patients. In PHGG patients, only chemotherapy (p = 0.023) was associated with OS while tumor size was marginally prognostic for OS (p = 0.051). Additional independent analysis of 2734 PLGG and 741 PHGG from the SEER database corroborated that larger tumor size was associated with decreased OS in LGG (p = 0.001) and HGG (p < 0.001) patients, separately. Conclusion In this study, we found that tumor size was a significant prognostic factor for the OS of PLGG patients in our series. Besides the tumor size, the extent of resection also independently impacted the prognosis of PLGG patients. While in PHGG patients, only chemotherapy was associated with improved OS and tumor size was marginally prognostic.


  • Open Access

    Editorial: Molecular characteristics and personalized treatment for pediatric brain tumors

    by Weijun Feng, Daisuke Kawauchi, Feng Wan

    Editorial: Molecular characteristics and personalized treatment for pediatric brain tumors


  • Open Access

    Application of weighted co-expression network analysis and machine learning to identify the pathological mechanism of Alzheimer's disease

    by Keping Chai, Xiaolin Zhang, Shufang Chen, Huaqian Gu, Huitao Tang, Panlong Cao, Gangqiang Wang, Weiping Ye, Feng Wan, Jiawei Liang, et al.

    Aberrant deposits of neurofibrillary tangles (NFT), the main characteristic of Alzheimer's disease (AD), are highly related to cognitive impairment. However, the pathological mechanism of NFT formation is still unclear. This study explored differences in gene expression patterns in multiple brain regions [entorhinal, temporal, and frontal cortex (EC, TC, FC)] with distinct Braak stages (0- VI), and identified the hub genes via weighted gene co-expression network analysis (WGCNA) and machine learning. For WGCNA, consensus modules were detected and correlated with the single sample gene set enrichment analysis (ssGSEA) scores. Overlapping the differentially expressed genes (DEGs, Braak stages 0 vs. I-VI) with that in the interest module, metascape analysis, and Random Forest were conducted to explore the function of overlapping genes and obtain the most significant genes. We found that the three brain regions have high similarities in the gene expression pattern and that oxidative damage plays a vital role in NFT formation via machine learning. Through further filtering of genes from interested modules by Random Forest, we screened out key genes, such as LYN, LAPTM5, and IFI30. These key genes, including LYN, LAPTM5, and ARHGDIB, may play an important role in the development of AD through the inflammatory response pathway mediated by microglia.


  • Dead Cas(t) light on new life: CRISPRa-mediated reprogramming of somatic cells into neurons

    by Meiling Zhou, Yu Cao, Ming Sui, Xiji Shu, Feng Wan, Bin Zhang

    Overexpression of exogenous lineage-specific transcription factors could directly induce terminally differentiated somatic cells into target cell types. However, the low conversion efficiency and the concern about introducing exogenous genes limit the clinical application. With the rapid progress in genome editing, the application of CRISPR/dCas9 has been expanding rapidly, including converting somatic cells into other types of cells in vivo and in vitro. Using the CRISPR/dCas9 system, direct neuronal reprogramming could be achieved by activating endogenous genes. Here, we will discuss the latest progress, new insights, and future challenges of the application of the dCas9 system in direct neuronal reprogramming.